Clinical Trial Update: Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

View source ↗

Summary

Update on a clinical trial evaluating invasive aspergillosis after allogeneic hematopoietic stem cell transplantation; current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Snippet

Sponsor: Ospedale Santa Croce-Carle Cuneo | Conditions: Hematological Diseases, Invasive Aspergillosis | Status: UNKNOWN